source · text/markdown
source_032d515230fa4e0f
sha256 3301250ef323e3d30e239f0a9f9cea9c918b34f40ce323123f3d2a1a648ecdac
by researka:v2 · 2026-07-01 16:09:46.885441+04:00
# Alpha memo: metformin resistance cross-context evidence signal **One-sentence alpha:** Animal work supports a biological premise for metformin combined with endurance-style training, whereas clinical data suggest that, in adults with type 2 diabetes, metformin does not add to the glycaemic benefit of aerobic, resistance, or combined training and may attenuate exercise-induced glycaemic gains. **Receipt 1:** Effects Of Metformin Administration With Swimming TVaining In Fructose Induced Insulin Resistance Rats (2007) – reports that combining metformin with swimming training was tested in fructose-induced insulin-resistant Wistar rats and asked whether the combination would further improve insulin sensitivity beyond either alone. **Receipt 2:** Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both? (2013) – in the DARE trial of adults with type 2 diabetes, aerobic training reduced HbA1c versus control in metformin users, with the authors noting prior suggestions that metformin might attenuate exercise effects on glycaemia or fitness. **Why this is surprising:** An animal model raised the plausibility that metformin would augment training-driven insulin sensitivity, yet the human DARE analysis (with prior attenuation signals) suggests the glycaemic additivity does not cleanly carry over to adults with type 2 diabetes. **Caveats/falsifiers:** - Receipt 1 is a 32-rat fructose-induced insulin-resistance model with N=8 per arm and tests swimming endurance, not free-living aerobic or resistance training, so species, dosing, and modality differences from Receipt 2 make the moderator hypothesis tentative and confounded by other axes; Receipt 2 is a secondary analysis of the DARE trial (n=143 metformin users, n=82 non-users within 251 randomised) restricted to people with established type 2 diabetes over ~22 weeks. - A decisive future falsifier would be a randomised trial in adults with type 2 diabetes showing that metformin plus aerobic, resistance, or combined training produces greater HbA1c reduction than training alone, with no interaction with metformin status.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "4c497ac8-8b82-4ee8-b723-8e60e4fb372d",
"title": "Alpha memo: metformin resistance cross-context evidence signal"
}